tetano
Editor, Senior Moderator
BMC Public Health
. 2024 Jun 28;24(1):1729.
doi: 10.1186/s12889-024-19274-3. Prevalence of Post-COVID conditions among Mexican COVID-19 survivors: a nationwide cross-sectional study
Yenisei Ramírez-Toscano[SUP] 1 [/SUP], Leticia Torres-Ibarra[SUP] 2 [/SUP], Martha Carnalla[SUP] 1 [/SUP], Ana Basto-Abreu[SUP] 1 [/SUP], Dèsirée Vidaña-Perez[SUP] 3 [/SUP], M Arantxa Colchero[SUP] 4 [/SUP], Sergio Bautista-Arredondo[SUP] 4 [/SUP], Sharon Saydah[SUP] 5 [/SUP], Tonatiuh Barrientos-Gutiérrez[SUP] 1 [/SUP]
Affiliations
Background: There are limited population-representative data that describe the potential burden of Post-COVID conditions (PCC) in Mexico. We estimated the prevalence of PCC overall and by sociodemographic characteristics among a representative sample of adults previously diagnosed with COVID-19 in Mexico. We additionally, characterized the PCC symptoms, and estimated the association between diagnosed type-2 diabetes and hypertension with PCC.
Methods: We used data from the 2021 National Health and Nutrition Survey in Mexico, a nationally and regionally representative survey, from August 1st to October 31st, 2021. Using the WHO definition, we estimated the prevalence of PCC by sociodemographics and prevalence of PCC symptoms. We fit multivariable log-binomial regression models to estimate the associations.
Results: The prevalence of PCC was 37.0%. The most common persistent symptoms were fatigue (56.8%), myalgia or arthralgia (47.5%), respiratory distress and dyspnea (42.7%), headache (34.0%), and cough (25.7%). The prevalence was higher in older people, women, and individuals with low socioeconomic status. There was no significant association between hypertension and PCC or diabetes and PCC prevalence.
Conclusions: About one-third of the adult Mexican population who had COVID-19 in 2021 had Post-COVID conditions. Our population-based estimates can help assess potential priorities for PCC-related health services, which is critical in light of our weak health system and limited funding.
Keywords: COVID-19; Epidemiology; Long COVID; Mexico; Population-based study; Post-COVID condition.
. 2024 Jun 28;24(1):1729.
doi: 10.1186/s12889-024-19274-3. Prevalence of Post-COVID conditions among Mexican COVID-19 survivors: a nationwide cross-sectional study
Yenisei Ramírez-Toscano[SUP] 1 [/SUP], Leticia Torres-Ibarra[SUP] 2 [/SUP], Martha Carnalla[SUP] 1 [/SUP], Ana Basto-Abreu[SUP] 1 [/SUP], Dèsirée Vidaña-Perez[SUP] 3 [/SUP], M Arantxa Colchero[SUP] 4 [/SUP], Sergio Bautista-Arredondo[SUP] 4 [/SUP], Sharon Saydah[SUP] 5 [/SUP], Tonatiuh Barrientos-Gutiérrez[SUP] 1 [/SUP]
Affiliations
- PMID: 38943168
- PMCID: PMC11212168
- DOI: 10.1186/s12889-024-19274-3
Background: There are limited population-representative data that describe the potential burden of Post-COVID conditions (PCC) in Mexico. We estimated the prevalence of PCC overall and by sociodemographic characteristics among a representative sample of adults previously diagnosed with COVID-19 in Mexico. We additionally, characterized the PCC symptoms, and estimated the association between diagnosed type-2 diabetes and hypertension with PCC.
Methods: We used data from the 2021 National Health and Nutrition Survey in Mexico, a nationally and regionally representative survey, from August 1st to October 31st, 2021. Using the WHO definition, we estimated the prevalence of PCC by sociodemographics and prevalence of PCC symptoms. We fit multivariable log-binomial regression models to estimate the associations.
Results: The prevalence of PCC was 37.0%. The most common persistent symptoms were fatigue (56.8%), myalgia or arthralgia (47.5%), respiratory distress and dyspnea (42.7%), headache (34.0%), and cough (25.7%). The prevalence was higher in older people, women, and individuals with low socioeconomic status. There was no significant association between hypertension and PCC or diabetes and PCC prevalence.
Conclusions: About one-third of the adult Mexican population who had COVID-19 in 2021 had Post-COVID conditions. Our population-based estimates can help assess potential priorities for PCC-related health services, which is critical in light of our weak health system and limited funding.
Keywords: COVID-19; Epidemiology; Long COVID; Mexico; Population-based study; Post-COVID condition.